Towards a global initiative for fibrosis treatment (GIFT)

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by increased scarring of lung tissue. Despite the recent introduction of novel drugs that slow disease progression, IPF remains a deadly disease, and the benefits of these new drugs differ markedly between patients. Huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina-Molina, Maria, Agusti, Alvar, Crestani, Bruno, Schwartz, David A., Königshoff, Melanie, Chambers, Rachel C., Maher, Toby M., Faner, Rosa, Mora, Ana Lucia, Rojas, Mauricio, Antoniou, Katerina M., Sellares, Jacobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710382/
https://www.ncbi.nlm.nih.gov/pubmed/29214157
http://dx.doi.org/10.1183/23120541.00106-2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710382/
https://www.ncbi.nlm.nih.gov/pubmed/29214157
http://dx.doi.org/10.1183/23120541.00106-2017

Ejemplares similares